First Patient Enrolled in RGN-137 Trial for Epidermolysis Bullosa Experiences Complete Wound Healing
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)...
Read MoreRegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX)...
Read MoreResearchers from the Los Angeles...
Read MoreAstellas Pharma Inc. (TSE: 4503,...
Read MoreAstraZeneca today announced that the...
Read MoreDaiichi Sankyo Company has announced...
Read MoreBiotechnology company Antikor Biopharma Ltd...
Read MoreEli Lilly and Company reported...
Read More1. Number of Post :...
Read MoreReflow Medical, Inc. announces that...
Read MoreBiopharmaceutical firm Biocon, on August...
Read More